These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26455511)

  • 1. Successful treatment of severe acute antibody-mediated rejection of renal allografts with bortezomib--a report of two pediatric cases.
    Roberti I; Vyas S
    Pediatr Transplant; 2015 Dec; 19(8):E189-92. PubMed ID: 26455511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.
    Pearl MH; Nayak AB; Ettenger RB; Puliyanda D; Palma Diaz MF; Zhang Q; Reed EF; Tsai EW
    Pediatr Nephrol; 2016 Aug; 31(8):1341-8. PubMed ID: 27048228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib for refractory acute antibody-mediated rejection in kidney transplant recipients: A single-centre case series.
    De Sousa-Amorim E; Revuelta I; Diekmann F; Cofan F; Lozano M; Cid J; Palou E; Sole M; Campistol JM; Oppenheimer F
    Nephrology (Carlton); 2016 Aug; 21(8):700-4. PubMed ID: 26492594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.
    Walsh RC; Everly JJ; Brailey P; Rike AH; Arend LJ; Mogilishetty G; Govil A; Roy-Chaudhury P; Alloway RR; Woodle ES
    Transplantation; 2010 Feb; 89(3):277-84. PubMed ID: 20145517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation.
    Sureshkumar KK; Hussain SM; Marcus RJ; Ko TY; Khan AS; Tom K; Vivas CA; Parris G; Jasnosz KM; Thai NL
    Clin Nephrol; 2012 Mar; 77(3):246-53. PubMed ID: 22377258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute antibody-mediated rejection using bortezomib: a case report.
    Sin YH; Kim YJ; Oh JS; Lee JH; Kim SM; Kim JK
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():86-9. PubMed ID: 26031595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lack of Lazarus effect with proteasome inhibition.
    Marks SD
    Pediatr Nephrol; 2016 Aug; 31(8):1217-9. PubMed ID: 27048227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Plasma Cell-Rich Acute Rejection in Living-Related Kidney Transplant: Role of Proteasome Inhibitor.
    Abbas K; Mubarak M; Zafar MN; Musharraf W; Imam M; Aziz T; Rizvi AH
    Exp Clin Transplant; 2019 Feb; 17(1):42-46. PubMed ID: 29534661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immunity and use of bortezomib for antibody-mediated rejection in a pediatric kidney transplant recipient.
    Claes DJ; Yin H; Goebel J
    Pediatr Transplant; 2014 Jun; 18(4):E100-5. PubMed ID: 24725066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.
    Eskandary F; Regele H; Baumann L; Bond G; Kozakowski N; Wahrmann M; Hidalgo LG; Haslacher H; Kaltenecker CC; Aretin MB; Oberbauer R; Posch M; Staudenherz A; Handisurya A; Reeve J; Halloran PF; Böhmig GA
    J Am Soc Nephrol; 2018 Feb; 29(2):591-605. PubMed ID: 29242250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib Eliminates Plasma Cells From a Renal Graft in Plasma Cell-Rich Acute Rejection.
    Tasaki M; Saito K; Nakagawa Y; Ikeda M; Imai N; Ito Y; Sudo M; Ikezumi Y; Yamada T; Hasegawa H; Kobayashi T; Miura K; Narita I; Takahashi K; Tomita Y
    Transplant Proc; 2019; 51(6):1732-1738. PubMed ID: 31301858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib-based treatment of acute antibody-mediated rejection: a case report.
    Wang Q; Li XL; Xu XG; Shi BY; Zhang ZM; Li ZL; Han Y; Zhou WQ; Chen CQ; Cai M; Zhang X
    Genet Mol Res; 2015 Dec; 14(4):17951-8. PubMed ID: 26782441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability of antibody removal following proteasome inhibitor-based therapy.
    Everly MJ; Terasaki PI; Trivedi HL
    Transplantation; 2012 Mar; 93(6):572-7. PubMed ID: 22262128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.
    Everly MJ; Everly JJ; Susskind B; Brailey P; Arend LJ; Alloway RR; Roy-Chaudhury P; Govil A; Mogilishetty G; Rike AH; Cardi M; Wadih G; Tevar A; Woodle ES
    Transplantation; 2008 Dec; 86(12):1754-61. PubMed ID: 19104417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of bortezomib treatment of antibody-mediated rejection in renal transplantation.
    Ejaz NS; Alloway RR; Halleck F; Dürr M; Budde K; Woodle ES
    Antioxid Redox Signal; 2014 Dec; 21(17):2401-18. PubMed ID: 24635140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib-based treatment of antibody mediated rejection in pancreas allograft recipients.
    Govil A; Walsh RC; Tevar A; Alloway R; Roy-Chaudhury P; Mogilishetty G; Wall GE; Brailey P; Girnita A; Woodle ES
    Clin Transpl; 2009; ():443-53. PubMed ID: 20524313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection.
    Hardinger KL; Murillo D
    Clin Transpl; 2011; ():401-8. PubMed ID: 22755438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction.
    Stuckey LJ; Kamoun M; Chan KM
    Ann Pharmacother; 2012 Jan; 46(1):e2. PubMed ID: 22202499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of bortezomib for reducing donor-specific antibodies in children and adolescents on a steroid minimization regimen.
    Nguyen S; Gallay B; Butani L
    Pediatr Transplant; 2014 Aug; 18(5):463-8. PubMed ID: 24814755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study.
    Kizilbash S; Claes D; Ashoor I; Chen A; Jandeska S; Matar RB; Misurac J; Sherbotie J; Twombley K; Verghese P
    Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28092129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.